Background: Low birthweight and major congenital malformations (MCMs) are key causes of infant mortality.

Objectives: The aim of this study was to explore the prevalence of MCMs in infants with low and very low birthweight and analyze the impact of MCMs and birthweight on infant mortality.

Methods: We determined prevalence and infant mortality of 28 life-threatening MCMs in very-low-birthweight (<1,500 g, VLBW), low-birthweight (1,500-2,499 g, LBW), or normal-birthweight (≥2,500 g, NBW) infants in a cohort of 2,727,002 infants born in Germany in 2006-2017, using de-identified administrative data of the largest statutory public health insurance system in Germany.

Results: The rates of VLBW, LBW, and NBW infants studied were 1.3% (34,401), 4.0% (109,558), and 94.7% (2,583,043). MCMs affected 0.5% (13,563) infants, of whom >75% (10,316) had severe congenital heart disease. The prevalence (per 10,000) of any/cardiac MCM was increased in VLBW (286/176) and LBW (244/143), as compared to NBW infants (38/32). Infant mortality rates were significantly higher in infants with an MCM, as opposed to infants without an MCM, in each birthweight group (VLBW 28.5% vs. 11.5%, LBW 16.7% vs. 0.9%, and NBW 8.6% vs. 0.1%). For most MCMs, observed survival rates in VLBW and LBW infants were lower than expected, as calculated from survival rates of VLBW or LBW infants without an MCM, and NBW infants with an MCM.

Conclusions: Infants with an MCM are more often born with LBW or VLBW, as opposed to infants without an MCM. Many MCMs carry significant excess mortality when occurring in VLBW or LBW infants.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000520113DOI Listing

Publication Analysis

Top Keywords

infants mcm
20
infant mortality
12
vlbw lbw
12
lbw infants
12
infants
10
prevalence infant
8
major congenital
8
congenital malformations
8
low birthweight
8
nbw infants
8

Similar Publications

Aim: To compare glycemic control and maternal-fetal outcomes of women with type 1 diabetes (T1D) using Minimed™ 780G (MM780G) with those women using Minimed™ 640G (MM640G) since before pregnancy.

Methods: Multicenter prospective cohort study of pregnant women with T1D in Spain. We evaluated HbA1c, time spent within (TIRp), below (TBRp) and above (TARp) the pregnancy-specific glucose range 3.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to examine the relationship between the use of tetracycline antibiotics during the first trimester of pregnancy and the risk of major congenital malformations (MCMs) in infants.
  • - Researchers analyzed data from a cohort of over 1.2 million single infants born in Sweden between 2006 and 2018, with a focus on comparing those exposed to tetracyclines against those who were not.
  • - Results showed that there was no significant difference in the occurrence of MCMs between the two groups, indicating that tetracycline use during early pregnancy is not linked to higher risks of MCMs.
View Article and Find Full Text PDF
Article Synopsis
  • This study examines how the different presentations of posterior fossa arachnoid cysts (PFACs) affect surgical decisions and patient outcomes in children.
  • A "wait and see" approach is recommended for asymptomatic patients, leading to better outcomes at one year; surgery types like fenestration or shunting show no significant difference in outcomes, but cyst location does matter.
  • Factors such as patient age, presence of hydrocephalus, and cyst location are crucial in determining the best treatment to reduce complications and improve results after surgery.
View Article and Find Full Text PDF

Viral respiratory diseases place a heavy burden on the healthcare system, with children making up a significant portion of related hospitalizations. While comorbidities increase the risk of complications and poor outcomes, many hospitalized children lack clear risk factors. As new vaccines for respiratory viral diseases emerge, this study examined pediatric respiratory hospitalizations, focusing on viral etiology, complication rates, and the impact of comorbidities to guide future policy.

View Article and Find Full Text PDF

Tuberculosis (TB), caused by Mycobacterium tuberculosis, is one of the leading causes of death due to an infectious agent. Coinfection with HIV exacerbates M. tuberculosis infection outcomes in people living with HIV.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!